Better imaging techniques for heart tissue damage in atrial fibrillation
Improved Imaging of Fibrosis in Atrial Fibrillation
This study is working on a new way to take MRI pictures of the heart to help doctors see and measure scarring in the left atrium of patients with atrial fibrillation, making it easier for them to get accurate diagnoses and better treatment plans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11045715 on NIH RePORTER |
What this research studies
This research focuses on improving MRI imaging methods to better visualize and quantify fibrosis in the left atrium of patients with atrial fibrillation. By developing a new MRI technique combined with machine learning, the study aims to enhance the reliability and repeatability of imaging results, which are crucial for assessing heart tissue damage. The approach seeks to reduce the need for expert supervision in interpreting images, making it more accessible for clinical use. Patients may benefit from more accurate diagnoses and treatment plans based on improved imaging of their heart condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with atrial fibrillation who may require imaging to assess heart tissue damage.
Not a fit: Patients without atrial fibrillation or those who are not eligible for MRI imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate assessments of heart tissue damage, improving treatment outcomes for patients with atrial fibrillation.
How similar studies have performed: Previous research has shown promise in improving imaging techniques for cardiac conditions, suggesting that this approach could yield significant advancements.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Dibella, Edward Vr — University of Utah
- Study coordinator: Dibella, Edward Vr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.